Skip to main content
Top
Published in: Indian Journal of Gastroenterology 4/2017

01-07-2017 | Original Article

Changes in adiposity and other cardiometabolic risk factors following Roux-en-Y gastric bypass: A 12-month prospective cohort study in Chinese patients

Authors: Mohsen Mazidi, Hong-kai Gao, Han Hui, Liang Li, Gordon A. Ferns

Published in: Indian Journal of Gastroenterology | Issue 4/2017

Login to get access

Abstract

Aim

We aimed to investigate the changes in adiposity and other cardiometabolic risk factors in the year following Roux-en-Y gastric bypass (RYGB) in patients of Chinese ethnicity.

Methods

The study recruited 209 patients who met the indications for bariatric surgery. Adiposity and cardiometabolic risk factors were assessed at baseline and over the 12 months following surgery in all participants. SPSS® software was used for statistical analysis.

Results

The mean body mass index (BMI) was 29.98 kg/m2 at baseline and steadily decreased to 25.32 kg/m2 at 12 months, giving a relative change of −15.5% (p < 0.001). All of the lipid profile fractions except high-density lipoprotein (HDL) declined during the first 12 months of follow up; serum HDL increased during this time (all ANOVA p < 0.001). The mean fasting plasma glucose was 9.49 mmol/L at baseline and gradually decreased to 5.69 mmol/L at 12 months, giving a relative change of −40.0% (p < 0.001).

Conclusion

Following the RYGB procedure, changes in measures of adiposity were paralleled by a significant improvement in cardiometabolic factors for 12 months after surgery.
Literature
1.
go back to reference Ahima RS, Lazar MA. Physiology. The health risk of obesity—better metrics imperative. Science. 2013;341:856–8. Ahima RS, Lazar MA. Physiology. The health risk of obesity—better metrics imperative. Science. 2013;341:856–8.
2.
go back to reference Wang YC, McPherson K, Marsh T, Gortmaker SL, Brown M. Health and economic burden of the projected obesity trends in the USA and the UK. Lancet. 2011;378:815–25.CrossRefPubMed Wang YC, McPherson K, Marsh T, Gortmaker SL, Brown M. Health and economic burden of the projected obesity trends in the USA and the UK. Lancet. 2011;378:815–25.CrossRefPubMed
3.
go back to reference Kimokoti RW, Millen BE. Diet, the global obesity epidemic, and prevention. J Am Diet Assoc. 2011;111:1137–40.CrossRefPubMed Kimokoti RW, Millen BE. Diet, the global obesity epidemic, and prevention. J Am Diet Assoc. 2011;111:1137–40.CrossRefPubMed
5.
go back to reference Kouris-Blazos A, Wahlqvist ML. Health economics of weight management: evidence and cost. Asia Pac J Clin Nutr. 2007;16 Suppl 1:329–38.PubMed Kouris-Blazos A, Wahlqvist ML. Health economics of weight management: evidence and cost. Asia Pac J Clin Nutr. 2007;16 Suppl 1:329–38.PubMed
6.
go back to reference Hafeez S, Ahmed MH. Bariatric surgery as potential treatment for nonalcoholic fatty liver disease: a future treatment by choice or by chance? J Obes. 2013;2013:839275.CrossRefPubMedPubMedCentral Hafeez S, Ahmed MH. Bariatric surgery as potential treatment for nonalcoholic fatty liver disease: a future treatment by choice or by chance? J Obes. 2013;2013:839275.CrossRefPubMedPubMedCentral
7.
go back to reference Fallahi-Shahabad S, Mazidi M, Tavasoli A, et al. Metabolic improvement of morbid obese patients following Roux-en-Y gastric bypass surgery: a prospective study in Mashhad. Iran Indian J Gastroenterol. 2016;35:195–200.CrossRefPubMed Fallahi-Shahabad S, Mazidi M, Tavasoli A, et al. Metabolic improvement of morbid obese patients following Roux-en-Y gastric bypass surgery: a prospective study in Mashhad. Iran Indian J Gastroenterol. 2016;35:195–200.CrossRefPubMed
8.
go back to reference Mazidi M, de Caravatto PP, Speakman JR, Cohen RV.Mechanisms of action of surgical interventions on weight-related diseases: the potential role of bile acids. Obes Surg. 2017;27:826–36. Mazidi M, de Caravatto PP, Speakman JR, Cohen RV.Mechanisms of action of surgical interventions on weight-related diseases: the potential role of bile acids. Obes Surg. 2017;27:826–36.
9.
go back to reference Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683–93.CrossRefPubMed Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683–93.CrossRefPubMed
10.
go back to reference Sjöström L, Peltonen M, Jacobson P, et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA. 2014;311:2297–304.CrossRefPubMed Sjöström L, Peltonen M, Jacobson P, et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA. 2014;311:2297–304.CrossRefPubMed
11.
go back to reference le Roux CW, Welbourn R, Werling M, et al. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg. 2007;246:780–5.CrossRefPubMed le Roux CW, Welbourn R, Werling M, et al. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg. 2007;246:780–5.CrossRefPubMed
12.
go back to reference Romero F, Nicolau J, Flores L, et al. Comparable early changes in gastrointestinal hormones after sleeve gastrectomy and Roux-En-Y gastric bypass surgery for morbidly obese type 2 diabetic subjects. Surg Endosc. 2012;26:2231–9.CrossRefPubMed Romero F, Nicolau J, Flores L, et al. Comparable early changes in gastrointestinal hormones after sleeve gastrectomy and Roux-En-Y gastric bypass surgery for morbidly obese type 2 diabetic subjects. Surg Endosc. 2012;26:2231–9.CrossRefPubMed
13.
go back to reference Mazidi M, Rezaie P, Karimi E, Kengne AP.The effects of bile acid sequestrants on lipid profile and blood glucose concentrations: A systematic review and meta-analysis of randomized controlled trials. Int J Cardiol. 2017;227:850–7. Mazidi M, Rezaie P, Karimi E, Kengne AP.The effects of bile acid sequestrants on lipid profile and blood glucose concentrations: A systematic review and meta-analysis of randomized controlled trials. Int J Cardiol. 2017;227:850–7.
14.
go back to reference Gloy VL, Briel M, Bhatt DL, et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ. 2013;347:f5934.CrossRefPubMedPubMedCentral Gloy VL, Briel M, Bhatt DL, et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ. 2013;347:f5934.CrossRefPubMedPubMedCentral
15.
go back to reference Mazidi M, Gao HK, Li L, Hui H, Zhang Ye. Effects of Roux-en-Y gastric bypass on insulin secretion and sensitivity, glucose homeostasis, and diabetic control: A prospective cohort study in Chinese patients. Surgery. 2017; 161:1423–9. Mazidi M, Gao HK, Li L, Hui H, Zhang Ye. Effects of Roux-en-Y gastric bypass on insulin secretion and sensitivity, glucose homeostasis, and diabetic control: A prospective cohort study in Chinese patients. Surgery. 2017; 161:1423–9.
16.
go back to reference Burtis CA, Ashwood ER, De B. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. Fourth edition: Philadelphia: Elsevier Saunders; 2001. Burtis CA, Ashwood ER, De B. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. Fourth edition: Philadelphia: Elsevier Saunders; 2001.
17.
go back to reference Ikramuddin S, Kendrick M, Kellogg T, Sarr M. Open and laparoscopic Roux-en-Y gastric bypass: our techniques. J Gastrointest Surg. 2007;11:217–28.CrossRefPubMed Ikramuddin S, Kendrick M, Kellogg T, Sarr M. Open and laparoscopic Roux-en-Y gastric bypass: our techniques. J Gastrointest Surg. 2007;11:217–28.CrossRefPubMed
20.
go back to reference Carlsson LMS, Peltonen M, Ahlin S, et al. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med. 2012;367:695–704.CrossRefPubMed Carlsson LMS, Peltonen M, Ahlin S, et al. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med. 2012;367:695–704.CrossRefPubMed
21.
go back to reference Aminian A, Daigle CR, Romero-Talamás H, et al. Risk prediction of complications of metabolic syndrome before and 6 years after gastric bypass. Surg Obes Relat Dis. 2014;10:576–82.CrossRefPubMed Aminian A, Daigle CR, Romero-Talamás H, et al. Risk prediction of complications of metabolic syndrome before and 6 years after gastric bypass. Surg Obes Relat Dis. 2014;10:576–82.CrossRefPubMed
22.
go back to reference Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes—3-year outcomes. N Engl J Med. 2014;370:2002–13.CrossRefPubMedPubMedCentral Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes—3-year outcomes. N Engl J Med. 2014;370:2002–13.CrossRefPubMedPubMedCentral
23.
go back to reference Mazidi M, Gao HK, Li L, Hui H, Zhang Ye. Effects of Roux-en-Y gastric bypass on insulin secretion and sensitivity, glucose homeostasis, and diabetic control: A prospective cohort study in Chinese patients. Surgery. 2017;161:1423–9. Mazidi M, Gao HK, Li L, Hui H, Zhang Ye. Effects of Roux-en-Y gastric bypass on insulin secretion and sensitivity, glucose homeostasis, and diabetic control: A prospective cohort study in Chinese patients. Surgery. 2017;161:1423–9.
24.
go back to reference Brandao I, Ramalho S, Pinto-Bastos A, et al. Metabolic profile and psychological variables after bariatric surgery: association with weight outcomes. Eat Weight Disord. 2015;20:513–8. Brandao I, Ramalho S, Pinto-Bastos A, et al. Metabolic profile and psychological variables after bariatric surgery: association with weight outcomes. Eat Weight Disord. 2015;20:513–8.
25.
go back to reference Strain GW, Saif T, Ebel F, et al. Lipid profile changes in the severely obese after laparoscopic sleeve gastrectomy (LSG), 1, 3, and 5 years after surgery. Obes Surg. 2015;25:285–9.CrossRefPubMed Strain GW, Saif T, Ebel F, et al. Lipid profile changes in the severely obese after laparoscopic sleeve gastrectomy (LSG), 1, 3, and 5 years after surgery. Obes Surg. 2015;25:285–9.CrossRefPubMed
26.
go back to reference Effect of bariatric surgery on adiposity and metabolic profiles: A prospective cohort study in Middle-Eastern patients.World J Diabetes 2017;8:374–380. Effect of bariatric surgery on adiposity and metabolic profiles: A prospective cohort study in Middle-Eastern patients.World J Diabetes 2017;8:374–380.
27.
go back to reference Puzziferri N, Roshek TB, Mayo HG, Gallagher R, Belle SH, Livingston EH. Long-term follow-up after bariatric surgery: a systematic review. JAMA. 2014;312:934–42.CrossRefPubMedPubMedCentral Puzziferri N, Roshek TB, Mayo HG, Gallagher R, Belle SH, Livingston EH. Long-term follow-up after bariatric surgery: a systematic review. JAMA. 2014;312:934–42.CrossRefPubMedPubMedCentral
28.
go back to reference Benaiges D, Flores-Le-Roux JA, Pedro-Botet J, et al. Impact of restrictive (sleeve gastrectomy) vs hybrid bariatric surgery (Roux-en-Y gastric bypass) on lipid profile. Obes Surg. 2012;22:1268–75.CrossRefPubMed Benaiges D, Flores-Le-Roux JA, Pedro-Botet J, et al. Impact of restrictive (sleeve gastrectomy) vs hybrid bariatric surgery (Roux-en-Y gastric bypass) on lipid profile. Obes Surg. 2012;22:1268–75.CrossRefPubMed
29.
go back to reference Asztalos BF, Swarbrick MM, Schaefer EJ, et al. Effects of weight loss, induced by gastric bypass surgery, on HDL remodeling in obese women. J Lipid Res. 2010;51:2405–12.CrossRefPubMedPubMedCentral Asztalos BF, Swarbrick MM, Schaefer EJ, et al. Effects of weight loss, induced by gastric bypass surgery, on HDL remodeling in obese women. J Lipid Res. 2010;51:2405–12.CrossRefPubMedPubMedCentral
30.
go back to reference Hanusch-Enserer U, Zorn G, Wojta J, et al. Non-conventional markers of atherosclerosis before and after gastric banding surgery. Eur Heart J. 2009;30:1516–24.CrossRefPubMed Hanusch-Enserer U, Zorn G, Wojta J, et al. Non-conventional markers of atherosclerosis before and after gastric banding surgery. Eur Heart J. 2009;30:1516–24.CrossRefPubMed
31.
go back to reference Lubrano C, Mariani S, Badiali M, et al. Metabolic or bariatric surgery? Long-term effects of malabsorptive vs restrictive bariatric techniques on body composition and cardiometabolic risk factors. Int J Obes. 2010;34:1404–14.CrossRef Lubrano C, Mariani S, Badiali M, et al. Metabolic or bariatric surgery? Long-term effects of malabsorptive vs restrictive bariatric techniques on body composition and cardiometabolic risk factors. Int J Obes. 2010;34:1404–14.CrossRef
32.
go back to reference Mazidi M, Karimi E, Rezaie P, Ferns GA. Treatment with GLP1 receptor agonists reduce serum CRP concentrations in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials. J Diabetes Complications. 2017;31:1237–42. Mazidi M, Karimi E, Rezaie P, Ferns GA. Treatment with GLP1 receptor agonists reduce serum CRP concentrations in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials. J Diabetes Complications. 2017;31:1237–42.
33.
go back to reference Puzziferri N, Roshek TB 3rd, Mayo HG, Gallagher R, Belle SH, Livingston EH. Long-term follow-up after bariatric surgery: a systematic review. JAMA. 2014;312:934–42.CrossRefPubMedPubMedCentral Puzziferri N, Roshek TB 3rd, Mayo HG, Gallagher R, Belle SH, Livingston EH. Long-term follow-up after bariatric surgery: a systematic review. JAMA. 2014;312:934–42.CrossRefPubMedPubMedCentral
34.
go back to reference Colquitt JL, Pickett K, Loveman E, Frampton GK. Surgery for weight loss in adults. Cochrane Database Syst Rev. 2014;8:CD003641. Colquitt JL, Pickett K, Loveman E, Frampton GK. Surgery for weight loss in adults. Cochrane Database Syst Rev. 2014;8:CD003641.
Metadata
Title
Changes in adiposity and other cardiometabolic risk factors following Roux-en-Y gastric bypass: A 12-month prospective cohort study in Chinese patients
Authors
Mohsen Mazidi
Hong-kai Gao
Han Hui
Liang Li
Gordon A. Ferns
Publication date
01-07-2017
Publisher
Springer India
Published in
Indian Journal of Gastroenterology / Issue 4/2017
Print ISSN: 0254-8860
Electronic ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-017-0774-0

Other articles of this Issue 4/2017

Indian Journal of Gastroenterology 4/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.